Liver surgery and ablation registry
Part of Cancer, Digestive system clinical trials.
This study collects information from people having surgery or ablation (a treatment that uses heat or cold to destroy tumors) for liver lesions, whether benign (non-cancerous) or malignant (cancerous). It aims to learn more about these treatments to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a liver lesion that is either benign or malignant.
- You are scheduled for surgery to remove the lesion or for an ablation procedure.
- You are not having a liver biopsy only (without any treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people having liver surgery for a non-cancerous tumor or for liver cancer (primary or cancer that spread to the liver). It doesn’t usually add treatment—your care is documented to help doctors learn and improve future decisions.
This study follows patients who are having a procedure called thermal ablation to treat liver tumors. It aims to learn more about how well the procedure works and how safe it is.
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This study tracks patients with small lung tumors that are treated with a robotic bronchoscope to destroy the tumor using heat. It aims to learn how well this procedure works over time.
This study compares two nonsurgical procedures for liver cancer: stereotactic radiosurgery (focused radiation) and radiofrequency ablation (heat therapy). It is for people whose tumor is in a tricky spot near major blood vessels or other structures, making surgery difficult, and who have not received prior treatment.
Hear when a new Benign Liver Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.